⌘K

Home/Filings/4/0001193125-25-238995

4//SEC Filing

Bizily Scott 4

Accession 0001193125-25-238995

CIK 0001650648other

View on SEC.gov Company Profile

Filed

Oct 13, 8:00 PM ET

Accepted

Oct 14, 4:04 PM ET

Size

4.8 KB

Accession

0001193125-25-238995

Insider Transaction Report

Form 4

Period: 2025-10-09

4D Molecular Therapeutics, Inc.FDMT

Chief Legal Officer

Transactions

Sale
Common Stock
2025-10-09$10.00/sh−2,408$24,080→ 5,188 total

Footnotes (1)

[F1]Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on June 6, 2025.

Documents

1 file

4
ownership.xmlPrimary
4

Issuer

4D Molecular Therapeutics, Inc.

CIK 0001650648

Entity typeother

Related Parties

1

filerCIK 0001920738

Filing Metadata

Form type: 4
Filed: Oct 13, 8:00 PM ET
Accepted: Oct 14, 4:04 PM ET
Size: 4.8 KB

View on SEC.gov